| Product Name | MF | CAS | Details |
|---|
| Itraconazole Epimer | Details |
| Atenolol Impurity 1 | C11H16N2O3 | 81346-71-6 | Details |
| Atenolol EP Impurity I | C13H20N2O3 | 1797116-92-7 | Details |
| Atenolol | C14H22N2O3 | 29122-68-7 | Details |
| Atenolol EP Impurity F | C25H35N3O6 | 87619-83-8 | Details |
| Atenolol EP Impurity E | C19H22N2O5 | 141650-31-9 | Details |
| Itraconazole Impurity G | Details |
| Itraconazole EP Impurity B | C35H38Cl2N8O4 | 854372-77-3 | Details |
| Atenolol EP Impurity D | C11H14ClNO3 | 115538-83-5 | Details |
| Gliclazide Impurity 5 | C8H10N2O3S | 39051-77-9 | Details |
| Gliclazide Impurity 6 | C8H10N2O3S | 1207714-41-7 | Details |
| Gliclazide | C15H21N3O3S | 21187-98-4 | Details |
| Gliclazide Impurity 1 | C15H19N3O5S | 38173-52-3 | Details |
| Gliclazide Impurity 2 | C9H11NO4S | 14437-03-7 | Details |
| Gliclazide Impurity 3 HCl | C7H15ClN2 | 58108-05-7 | Details |
| Gliclazide Impurity 4 | C8H9NO4S | 107628-27-3 | Details |
| Atenolol Impurity C | C11H13NO3 | 29122-69-8 | Details |
| Atenolol EP Impurity B | C11H15NO4 | 61698-76-8 | Details |
| Atenolol EP Impurity A | C8H9NO2 | 17194-82-0 | Details |
| Itraconazole Impurity 14 | C14H15Cl2N3O5S | 67914-86-7 | Details |
| N-Desalkyl Itraconazole | C31H30Cl2N8O4 | 89848-41-9 | Details |
| Itraconazole N-Glucuronide | Details |
| Itraconazole N-Formyl-Ethlene Impurity | C34H36Cl2N8O5 | 1199350-00-9 | Details |
| Itraconazole EP Impurity A | C23H29N5O2 | 252964-68-4 | Details |
| Itraconazole EP Impurity C | C34H36Cl2N8O4 | 74855-91-7 | Details |
| Itraconazole EP Impurity D | C34H36Cl2N8O4 | 89848-49-7 | Details |
| Itraconazole EP Impurity E | C35H38Cl2N8O4 | 252964-65-1 | Details |
| Itraconazole EP Impurity F | C35H38Cl2N8O4 | 89848-51-1 | Details |
| Itraconazole N-Oxide | Details |
| Gliclazide EP Impurity B | C7H12N2O | 54786-86-6 | Details |
| Orlistat | C29H53NO5 | 96829-58-2 | Details |
| Orlistat Related Compound D | C29H53NO5 | 130793-27-0 | Details |
| Gliclazide EP Impurity D | C15H20N2O3S | 1136426-19-1 | Details |
| Gliclazide EP Impurity G | Details |
| Gliclazide EP Impurity E | C15H19N3O3S | 1808087-53-7 | Details |
| Orlistat USP Related Compound A | C22H42O3 | 104872-06-2 | Details |
| Orlistat USP Related Compound B | C8H16N2O4 | 19740-72-8 | Details |
| Orlistat USP Related Compound C | C18H15OP | 791-28-6 | Details |
| Orlistat USP Related Compound E | C29H53NO5 | 1072902-75-0 | Details |
| Atenolol Impurity D | C14H22N2O3 | Details |
| Atenolol Impurity F | C8H8O3 | 156-38-7 | Details |
| Atenolol EP Impurity H | C14H20N2O2 | 29277-73-4 | Details |
| Atenolol EP Impurity G Sodium Salt | C14H21NO4 | 56392-14-4 | Details |
| Gliclazide EP Impurity C | C10H13NO4S | 5577-13-9 | Details |
| Gliclazide EP Impurity F | C15H21N3O3S | 1076198-18-9 | Details |
| Guaifenesin EP Impurity B | C10H14O4 | 14007-09-1 | Details |
| Lenalidomide | C13H13N3O3 | 191732-72-6 | Details |
| Lenalidomide Impurity 7 | C13H16N4O3 | 2197414-55-2 | Details |
| Lenalidomide Glucosides | Details |
| Linagliptin | C25H28N8O2 | 668270-12-0 | Details |
| Linagliptin Impurity 41 | C25H29BrN8O2 | 1638744-06-5 | Details |
| Linagliptin Impurity 15 | C27H30N8O3 | 1803079-49-3 | Details |
| Guaifenesin EP Impurity C | C20H26O7 | 1797132-23-0 | Details |
| Guaifenesin EP Impurity D | C17H20O5 | 16929-60-5 | Details |
| Guaifenesin | C10H14O4 | 93-14-1 | Details |
| Nicotinic Acid EP Impurity E;Isoniazid EP Impurity A | C6H5NO2 | 55-22-1 | Details |
| Isoniazid EP Impurity B | C6H6N2O | 1453-82-3 | Details |
| Isoniazid Impurity 1 | C12H8N4O | 15420-02-7 | Details |
| Linagliptin Impurity 18 | C22H23N7O2 | 1646355-34-1 | Details |
| Linagliptin Impurity 43 | C30H36N8O4 | 668273-75-4 | Details |
| Linagliptin Impurity 42 | C10H9BrN4O2 | 666816-98-4 | Details |
| Linagliptin Impurity 21 | C20H28N6O4 | 666816-91-7 | Details |
| Aciclovir ;Acyclovir EP Impurity K | C17H22N10O6 | 1797131-64-6 | Details |
| Aciclovir ;Acyclovir EP Impurity J | C14H16N10O4 | 166762-90-9 | Details |
| Acyclovir ;Aciclovir EP Impurity P | C7H9N5O2 | 23169-33-7 | Details |
| Aciclovir ;Acyclovir EP Impurity M | C12H15N5O5 | 91702-60-2 | Details |
| Linagliptin Impurity 27 | C25H28N8O2 | 1446263-38-2 | Details |
| Rosuvastatin EP Impurity G Sodium Salt | C22H28FN3O6S | 1242184-42-4 | Details |
| Rosuvastatin Impurity 73 | C21H24FN3O5S | 1797419-58-9 | Details |
| Rosuvastatin EP Impurity L | Details |
| Rosuvastatin EP Impurity C | C22H26FN3O6S | 1422619-13-3 | Details |
| Rosuvastatin EP Impurity C Sodium Salt | C22H27FN3NaO6S | 1620823-61-1 | Details |
| Rosuvastatin EP Impurity D | C22H26FN3O5S | 503610-43-3 | Details |
| Acyclovir ;Aciclovir EP Impurity F | C10H13N5O4 | 110104-37-5 | Details |
| Acyclovir ;Aciclovir EP Impurity L | C9H9N5O3 | 3056-33-5 | Details |
| Acyclovir ;Aciclovir EP Impurity C | C8H11N5O3 | 91702-61-3 | Details |
| Acyclovir ;Aciclovir EP Impurity A | C10H13N5O4 | 102728-64-3 | Details |
| Acyclovir ;Aciclovir EP Impurity G | C12H15N5O5 | 75128-73-3 | Details |
| Acyclovir ;Aciclovir Impurity H | C17H17N5O5 | 133186-23-9 | Details |
| Rosuvastatin EP Impurity K Sodium Salt | C22H26FN3O5S | 2290571-51-4 | Details |
| Rosuvastatin 4,6-Diene Impurity | C22H26FN3O5S | 1422954-13-9 | Details |
| 3-O-Ethyl Rosuvastatin | Details |
| Rosuvastatin EP Impurity M Sodium Salt | C22H29N3O6S | 847849-66-5 | Details |
| Metoclopramide EP Impurity F | C13H20ClN3O2 | 38339-95-6 | Details |
| Metoclopramide EP Impurity G | C14H22ClN3O3 | 171367-22-9 | Details |
| Metoclopramide EP Impurity H | C9H9NO4 | 50-86-2 | Details |
| Rosuvastatin EP Impurity I Calcium Salt | Details |
| Rosuvastatin Impurity H Sodium Salt | C22H28FN3O6S | 1335110-44-5 | Details |
| Rosuvastatin EP Impurity F | C29H40FN3O6S | 289042-12-2 | Details |
| Rosuvastatin Calcium Salt | C22H30CaFN3O6S | 147098-20-2 | Details |
| Mesalazine EP Impurity E | C7H7NO3 | 65-49-6 | Details |
| Mesalazine Impurity ZY2 | Details |
| Metoclopramide EP Impurity B | C11H12ClNO4 | 4093-31-6 | Details |
| Rosuvastatin EP Impurity A Sodium Salt | C25H34FN3NaO7S* | 1714147-50-8 | Details |
| N-Acetyl Metoclopramide HCl | Details |
| Rosuvastatin EP Impurity J Sodium Salt | Details |
| Rosuvastatin EP Impurity E Sodium Salt | Details |
| Dacomitinib | C24H25ClFN5O2 | 1110813-31-4 | Details |
| Dacomitinib Impurity 1 | C15H12ClFN4O | 179552-75-1 | Details |
| Dacomitinib Impurity ZY1 | Details |
| Product Total： Product Page： | ||||
| 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 | ||||